XML 34 R17.htm IDEA: XBRL DOCUMENT
v3.20.2

Financial Instruments | 12 Months Ended
--- | ---
Jun. 28, 2020
Fair Value Disclosures [Abstract] |
Financial Instruments | Financial Instruments Fair Value The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions. Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data. The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and leases, and foreign currency related derivative instruments. The estimated fair value of cash, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 14 - Long Term Debt and Other Borrowings for additional information regarding the fair value of the Company’s senior notes and convertible senior notes. Investments The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of June 28, 2020, and June 30, 2019:
| June 28, 2020
|  |  |  |  |  |  |  | (Reported Within)
Cost |  | Unrealized Gain |  | Unrealized (Loss) |  | Fair Value |  | Cash and Cash Equivalents |  | Investments |  | Restricted Cash & Investments |  | Other Assets
| (in thousands)
Cash | $ | 977,862 |  |  | $ | — |  |  | $ | — |  |  | $ | 977,862 |  |  | $ | 973,978 |  |  | $ | — |  |  | $ | 3,884 |  |  | $ | — |
Time deposit | 2,244,655 |  |  | — |  |  | — |  |  | 2,244,655 |  |  | 1,994,628 |  |  | — |  |  | 250,027 |  |  | — |
Level 1: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds | 1,709,350 |  |  | — |  |  | — |  |  | 1,709,350 |  |  | 1,709,350 |  |  | — |  |  | — |  |  | — |
U.S. Treasury and agencies | 552,088 |  |  | 373 |  |  | (9 | ) |  | 552,452 |  |  | 76,992 |  |  | 475,460 |  |  | — |  |  | — |
Mutual funds | 68,784 |  |  | 4,571 |  |  | (928 | ) |  | 72,427 |  |  | — |  |  | — |  |  | — |  |  | 72,427 |
Level 1 total | 2,330,222 |  |  | 4,944 |  |  | (937 | ) |  | 2,334,229 |  |  | 1,786,342 |  |  | 475,460 |  |  | — |  |  | 72,427 |
Level 2: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government-sponsored enterprises | 31,442 |  |  | 12 |  |  | — |  |  | 31,454 |  |  | 25,999 |  |  | 5,455 |  |  | — |  |  | — |
Foreign government bonds | 10,693 |  |  | 28 |  |  | (5 | ) |  | 10,716 |  |  | 2,540 |  |  | 8,176 |  |  | — |  |  | — |
Corporate notes and bonds | 1,405,615 |  |  | 5,344 |  |  | (302 | ) |  | 1,410,657 |  |  | 131,685 |  |  | 1,278,972 |  |  | — |  |  | — |
Mortgage backed securities - residential | 3,142 |  |  | 71 |  |  | — |  |  | 3,213 |  |  | — |  |  | 3,213 |  |  | — |  |  | — |
Mortgage backed securities - commercial | 23,660 |  |  | 144 |  |  | — |  |  | 23,804 |  |  | — |  |  | 23,804 |  |  | — |  |  | — |
Level 2 total | 1,474,552 |  |  | 5,599 |  |  | (307 | ) |  | 1,479,844 |  |  | 160,224 |  |  | 1,319,620 |  |  | — |  |  | — |
Total | $ | 7,027,291 |  |  | $ | 10,543 |  |  | $ | (1,244 | ) |  | $ | 7,036,590 |  |  | $ | 4,915,172 |  |  | $ | 1,795,080 |  |  | $ | 253,911 |  |  | $ | 72,427 |
| June 30, 2019
|  |  |  |  |  |  |  | (Reported Within)
Cost |  | Unrealized Gain |  | Unrealized (Loss) |  | Fair Value |  | Cash and Cash Equivalents |  | Investments |  | Restricted Cash & Investments |  | Other Assets
| (in thousands)
Cash | $ | 467,460 |  |  | $ | — |  |  | $ | — |  |  | $ | 467,460 |  |  | $ | 462,310 |  |  | $ | — |  |  | $ | 5,150 |  |  | $ | — |
Time deposit | 1,563,686 |  |  | — |  |  | — |  |  | 1,563,686 |  |  | 1,313,659 |  |  | — |  |  | 250,027 |  |  | — |
Level 1: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds | 1,644,659 |  |  | — |  |  | — |  |  | 1,644,659 |  |  | 1,644,659 |  |  | — |  |  | — |  |  | — |
U.S. Treasury and agencies | 465,655 |  |  | 283 |  |  | (24 | ) |  | 465,914 |  |  | 86,981 |  |  | 378,933 |  |  | — |  |  | — |
Mutual funds | 76,961 |  |  | 1,063 |  |  | (283 | ) |  | 77,741 |  |  | — |  |  | — |  |  | — |  |  | 77,741 |
Level 1 total | 2,187,275 |  |  | 1,346 |  |  | (307 | ) |  | 2,188,314 |  |  | 1,731,640 |  |  | 378,933 |  |  | — |  |  | 77,741 |
Level 2: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government-sponsored enterprises | 16,005 |  |  | 5 |  |  | (41 | ) |  | 15,969 |  |  | — |  |  | 15,969 |  |  | — |  |  | — |
Foreign government bonds | 24,408 |  |  | 35 |  |  | — |  |  | 24,443 |  |  | — |  |  | 24,443 |  |  | — |  |  | — |
Corporate notes and bonds | 1,466,167 |  |  | 2,310 |  |  | (99 | ) |  | 1,468,378 |  |  | 150,610 |  |  | 1,317,768 |  |  | — |  |  | — |
Mortgage backed securities - residential | 6,148 |  |  | — |  |  | (4 | ) |  | 6,144 |  |  | — |  |  | 6,144 |  |  | — |  |  | — |
Mortgage backed securities - commercial | 29,587 |  |  | 140 |  |  | — |  |  | 29,727 |  |  | — |  |  | 29,727 |  |  | — |  |  | — |
Level 2 total | 1,542,315 |  |  | 2,490 |  |  | (144 | ) |  | 1,544,661 |  |  | 150,610 |  |  | 1,394,051 |  |  | — |  |  | — |
Total | $ | 5,760,736 |  |  | $ | 3,836 |  |  | $ | (451 | ) |  | $ | 5,764,121 |  |  | $ | 3,658,219 |  |  | $ | 1,772,984 |  |  | $ | 255,177 |  |  | $ | 77,741 |
The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. Additionally, the Company considers factors such as the Company’s intent to sell the security and whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. During the fiscal year 2018, the Company recorded a $42.5 million other-than-temporary impairment charge on a portion of its available for sale investments as a result of a decision to sell selected investments held in foreign jurisdictions in conjunction with our cash repatriation strategy following the U.S. tax reform legislation. The Company did not recognize any losses on investments due to other-than-temporary impairments in fiscal year 2020 or 2019. Gross realized gains/(losses) from sales of investments were insignificant in the fiscal years 2020, 2019, and 2018. The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions:
| June 28, 2020
Unrealized Losses Less than 12 Months |  | Unrealized Losses 12 Months or Greater |  | Total
Fair Value |  | Gross Unrealized Loss |  | Fair Value |  | Gross Unrealized Loss |  | Fair Value |  | Gross Unrealized Loss
| (in thousands)
U.S. Treasury and agencies | $ | 189,437 |  |  | $ | (9 | ) |  | $ | — |  |  | $ | — |  |  | $ | 189,437 |  |  | $ | (9 | )
Mutual funds | 2,623 |  |  | (289 | ) |  | 5,011 |  |  | (639 | ) |  | 7,634 |  |  | (928 | )
Foreign government bonds | 9,056 |  |  | (5 | ) |  | — |  |  | — |  |  | 9,056 |  |  | (5 | )
Corporate notes and bonds | 332,924 |  |  | (302 | ) |  | — |  |  | — |  |  | 332,924 |  |  | (302 | )
| $ | 534,040 |  |  | $ | (605 | ) |  | $ | 5,011 |  |  | $ | (639 | ) |  | $ | 539,051 |  |  | $ | (1,244 | )
The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities as of June 28, 2020, are as follows:
| Cost |  | Estimated Fair Value
| (in thousands)
Due in one year or less | $ | 5,527,654 |  |  | $ | 5,529,241 |
Due after one year through five years | 433,973 |  |  | 437,872 |
Due in more than five years | 19,018 |  |  | 19,188 |
| $ | 5,980,645 |  |  | $ | 5,986,301 |
The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 1 2 months. Accordingly, those investments with contractual maturities greater than 1 2 months from the date of purchase nonetheless are classified as short-term on the accompanying Consolidated Balance Sheets. Derivative Instruments and Hedging The Company carries derivative financial instruments (“derivatives”) on its Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. In addition, the Company enters into interest rate swap arrangements to manage interest rate risk. The counterparties to these derivatives are large, global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material. Cash Flow Hedges The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows, primarily from Japanese yen-denominated revenues and euro-denominated and Korean won-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that generally expire within 12 months and no later than 24 months. These hedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized. In addition, the Company has entered into interest rate swap agreements to hedge against the variability of cash flows due to changes in certain benchmark interest rates on fixed rate debt. These instruments are designated as cash flow hedges at inception and are settled in conjunction with the issuance of debt. The effective portion of the contracts’ gains or losses is included in accumulated other comprehensive income (loss) and is amortized into income as the hedged item impacts earnings. During the year ended June 28, 2020, the Company entered into and settled a series of these interest rate swap arrangements with a notional value of $400 million. During the year ended June 28, 2020, the company recognized a net loss of $31.5 million of accumulated other comprehensive income, net of tax, related to these interest rate swap agreements. As of June 28, 2020, $31.1 million of losses related to these interest rate swap arrangements remain in accumulated other comprehensive income, which it expects to reclassify from other comprehensive income into earnings over the next 10.0 years. At inception and at each quarter-end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of foreign exchange contracts due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating to both the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged, and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no material gains or losses during the fiscal years ended June 28, 2020, June 30, 2019, or June 24, 2018 associated with forecasted transactions that failed to occur. There were no material gains or losses during the fiscal years ended June 30, 2019, or June 24, 2018 associated with ineffectiveness. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. As of June 28, 2020, the Company had a net gain of $0.3 million accumulated in other comprehensive income, net of tax, related to foreign exchange cash flow hedges which it expects to reclassify from other comprehensive income into earnings over the next 12 months. Additionally, as of June 28, 2020, the Company had a net loss of $2.0 million accumulated in other comprehensive income, net of tax, related to interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 4.7 years. Fair Value Hedges The Company had interest rate contracts whereby the Company received fixed rates and paid variable rates based on certain benchmark interest rates, resulting in a net increase or decrease to interest expense, a component of other expense, net in our Consolidated Statement of Operations. These interest rate contracts were designated as fair value hedges and hedged against changes in the fair value of our debt portfolio. The Company concluded that these interest rate contracts met the criteria necessary to qualify for the short-cut method of hedge accounting, and as such, an assumption was made that the change in the fair value of the hedged debt, due to changes in the benchmark rate, exactly offset the change in the fair value of the interest rate swap. Therefore, the derivative was considered to be effective at achieving offsetting changes in the fair value of the hedged liability, and no ineffectiveness was recognized. During the year ended June 28, 2020, the Company terminated and consequently discontinued the hedging relationship of these interest rate contracts, refer to Note 14 - Long-Term Debt and Other borrowings for additional information regarding the accumulated fair value adjustment and the related amortization. Balance Sheet Hedges The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense). As of June 28, 2020, the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge programs:
| Notional Value
| Derivatives Designated as Hedging Instruments: |  | Derivatives Not Designated as Hedging Instruments:
| (in thousands)
Foreign currency forward contracts |  |  |  |  |  |  |
| Buy Contracts |  | Sell Contracts |  | Buy Contracts |  | Sell Contracts
Japanese yen | $ | — |  |  | $ | 299,450 |  |  | $ | 22,475 |  |  | $ | — |
Euro | 54,512 |  |  | — |  |  | 36,113 |  |  | — |
Korean won | 20,492 |  |  | — |  |  | — |  |  | 50,715 |
Taiwan dollar | — |  |  | — |  |  | 47,612 |  |  | — |
Chinese renminbi | — |  |  | — |  |  | 35,071 |  |  | — |
Swiss franc | — |  |  | — |  |  | 12,672 |  |  | — |
British pound sterling | — |  |  | — |  |  | 11,191 |  |  | — |
Singapore dollar | — |  |  | — |  |  | 10,062 |  |  | — |
Indian rupee | — |  |  | — |  |  | 7,772 |  |  | — |
Malaysian ringgit | — |  |  | — |  |  | 5,612 |  |  | — |
| $ | 75,004 |  |  | $ | 299,450 |  |  | $ | 188,580 |  |  | $ | 50,715 |
The fair value of derivative instruments in the Company’s Consolidated Balance Sheet as of June 28, 2020, and June 30, 2019, were as follows:
| June 28, 2020 |  | June 30, 2019
Fair Value of Derivative Instruments (Level 2) |  | Fair Value of Derivative Instruments (Level 2)
Derivative Assets |  | Derivative Liabilities |  | Derivative Assets |  | Derivative Liabilities
Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value
| (in thousands)
Derivatives designated as hedging instruments:
Foreign exchange contracts | Prepaid expense and other assets |  | $ | 1,862 |  |  | Accrued expenses and other current liabilities |  | $ | 1,405 |  |  | Prepaid expense and other assets |  | $ | 119 |  |  | Accrued expenses and other current liabilities |  | $ | 2,756 |
Interest rate contracts, short-term |  |  | — |  |  |  |  | — |  |  |  |  | — |  |  | Accrued expenses and other current liabilities |  | 5,149 |
Interest rate contracts, long-term |  |  | — |  |  |  |  | — |  |  | Other assets |  | 1,537 |  |  |  |  | — |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |
Foreign exchange contracts | Prepaid expense and other assets |  | 155 |  |  | Accrued expenses and other current liabilities |  | 70 |  |  | Prepaid expense and other assets |  | 1,249 |  |  | Accrued expenses and other current liabilities |  | 748 |
Total derivatives |  |  | $ | 2,017 |  |  |  |  | $ | 1,475 |  |  |  |  | $ | 2,905 |  |  |  |  | $ | 8,653 |
Under the master netting agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis on its balance sheet. As of June 28, 2020, the potential effect of rights of offset associated with the above foreign exchange and interest rate contracts would be an offset to assets and liabilities by $0.9 million, resulting in a net derivative asset of $1.1 million and net derivative liability of $0.6 million. As of June 30, 2019, the potential effect of rights of offset associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $2.4 million, resulting in a net derivative asset of $0.5 million and a net derivative liability of $6.2 million. The Company is not required to pledge, nor is the Company entitled to receive, cash collateral for these derivative transactions. The effect of derivative instruments designated as cash flow hedges on the Company’s Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”), was as follows:
|  | Year Ended June 28, 2020 |  | Year Ended June 30, 2019
| Location of Gain (Loss) Recognized in or Reclassified into Income | Gain (Loss) Recognized in AOCI |  | Gain (Loss) Reclassified from AOCI into Income |  | Gain (Loss) Recognized in AOCI |  | Gain (Loss) Reclassified from AOCI into Income
Derivatives in Cash Flow Hedging Relationships | (in thousands)
Foreign exchange contracts | Revenue | $ | 4,095 |  |  | $ | 2,418 |  |  | $ | 8,143 |  |  | $ | 10,821 |
Foreign exchange contracts | Cost of goods sold | (2,104 | ) |  | (3,101 | ) |  | (3,801 | ) |  | (5,949 | )
Foreign exchange contracts | SG&A | (1,158 | ) |  | (1,501 | ) |  | (1,618 | ) |  | (2,321 | )
Interest rate contracts | Other expense, net | (40,610 | ) |  | (700 | ) |  | — |  |  | (134 | )
|  | $ | (39,777 | ) |  | $ | (2,884 | ) |  | $ | 2,724 |  |  | $ | 2,417 |
The effect of derivative instruments not designated as cash flow hedges on the Company’s Consolidated Statement of Operations was as follows:
| Year Ended
June 28, 2020 |  | June 30, 2019
Derivatives Not Designated as Hedging Instruments: | Location of (Loss) Gain Recognized in Income | Loss Recognized in Income |  | Gain Recognized in Income
|  | (in thousands)
Foreign exchange contracts | Other income | $ | (5,971 | ) |  | $ | 4,124 |
The following table presents the effect of the fair value cash flow hedge accounting on the Statement of Financial Performance as well as presents the location and amount of gain/(loss) recognized in Income on fair value and cash flow hedging relationships:
| Location and Amount of Gain (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
| Year ended
| June 28, 2020
| Revenue |  | Cost of Goods Sold |  | Selling, General and Administrative |  | Other Income (Expense)
| (in thousands)
Total amounts of income and expense line items presented in the statement of financial performance in which the effects of fair value or cash flow hedges are recorded:
| $ | 10,044,736 |  |  | $ | 5,436,043 |  |  | $ | 682,479 |  |  | $ | (98,824 | )
The effects of fair value and cash flow hedging: |  |  |  |  |  |  |
Gain or (loss) on fair value hedging relationships in Subtopic 815-20: |  |  |  |
Interest contracts: |  |  |  |  |  |  |
Hedged items | — |  |  | — |  |  | — |  |  | (12,882 | )
Derivatives designated as hedging instruments | — |  |  | — |  |  | — |  |  | 12,882 |
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20: |  |  |  |
Foreign exchange contracts: |  |  |  |  |  |  |
Amount of gain or (loss) reclassified from accumulated other comprehensive income into income | 2,418 |  |  | (3,101 | ) |  | (1,501 | ) |  | — |
Interest rate contracts: |  |  |  |  |  |  |
Amount of gain (loss) reclassified from accumulated other comprehensive income into income | — |  |  | — |  |  | — |  |  | (700 | )
Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large, global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances. The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer. The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations and on contracts related to structured share repurchase arrangements. These counterparties are large, global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company. Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers, and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales. As of June 28, 2020, two customers accounted for approximately 21% and 12%, of accounts receivable, respectively. As of June 30, 2019, four customers accounted for approximately 18%, 15%, 11%, and 10% of accounts receivable, respectively. No other customers accounted for more than 10% of accounts receivable, respectively. The Company’s balance and transactional activity for its allowance for doubtful accounts is not material as of and for the twelve months ended June 28, 2020, June 30, 2019, and June 24, 2018.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration